ALEXANDRIA, Va., July 16 -- United States Patent no. 12,360,126, issued on July 15, was assigned to Cleveland Heartlab Inc. (Cleveland).

"HDL-associated protein biomarker panel detection" was invented by Cory Bystrom (Cleveland) and Timothy Collier (Cleveland).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods, systems, and compositions for detecting one or more HDL-associated proteins (e.g., ApoC3; ApoC3 and ApoA1; ApoC3 and SAA1/2; or proteins in Biomarker Panels 1-30) in a sample from a subject with, or suspected of having, cardiovascular disease (CVD) or other HDL related disease. In certain embodiments, such methods, systems, and compositions are used to determine the approximate ...